EGM
AVIR icon

Engineers Gate Manager’s Atea Pharmaceuticals AVIR Stock Holding History

Engineers Gate Manager’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.1K Buy
+16,806
New +$83.6K ﹤0.01% 2092
2022
Q1 		– Sell
-35,924
Closed -$321K – 1848
2021
Q4 		$321K Buy
+35,924
New +$560K 0.01% 1352
2021
Q3 		– Sell
-22,848
Closed -$491K – 1635
2021
Q2 		$491K Buy
+22,848
New +$687K 0.03% 838

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Engineers Gate Manager's AVIR Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Atea Pharmaceuticals (AVIR) in Q2 2026: 16,806 shares worth $78.1K. The stake represents ﹤0.01% of the portfolio and ranks #2092 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in AVIR as recently as Q4 2021.

Engineers Gate Manager first reported a position in AVIR in Q2 2021 and has held it in 3 quarters since. The position peaked at $491K in Q2 2021. 125 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Engineers Gate Manager held 16,806 shares of Atea Pharmaceuticals worth $78.1K as of Q2 2026.
  • Atea Pharmaceuticals was a new Engineers Gate Manager position in Q2 2026.
  • Atea Pharmaceuticals made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2092 holding.
  • Engineers Gate Manager first reported a position in Atea Pharmaceuticals in Q2 2021 and has held it in 3 quarters since.
  • Engineers Gate Manager's Atea Pharmaceuticals position peaked at $491K in Q2 2021.
  • 125 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.